Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The aim of this randomized prospective study in renal transplant recipients is to investigate
immunological short and long-term effects of an IVIG induction therapy.
Furthermore clinical endpoints (patient and graft survival, incidence of acute and chronic
rejection, infectious diseases and graft function) up to three years posttransplant will be
analyzed.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Giessen
Collaborators:
Astellas Pharma Inc Aventis Pharmaceuticals Heidelberg University Hoffmann-La Roche